Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome

Critical Care Medicine

Volumn 35, Issue 5, 2007, Pages 1369-1375

  Wittkowski, Helmut ^a   Sturrock, Anne ^b   Van Zoelen, Marieke A D ^c   Viemann, Dorothee ^a   Van Der Poll, Tom ^c   Hoidal, John R ^b   Roth, Johannes ^a   Foell, Dirk ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute respiratory distress syndrome; Lung; Neutrophils; Receptor for advanced glycation end products; S100A12

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; LIPOPOLYSACCHARIDE; PLACEBO; PROTEIN S 100; S100 A12 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; LUNG BIOPSY; LUNG INJURY; MALE; NEUTROPHIL; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY DISTRESS SYNDROME; TRACHEOBRONCHIAL TOILET;

EID: 34247361667     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000262386.32287.29     Document Type: Article

References (38)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
2. Lee WL, Downey GP: Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001; 7:1-7
3. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5:331-342
4. Abraham E, Arcaroli J, Carmody A, et al: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165:2950-2954
5. Foell D, Wittkowski H, Vogl T, et al: S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007; 81:28-37
6. Schmidt AM, Yan SD, Yan SF, et al: The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108:949-955
7. Hofmann MA, Drury S, Fu C, et al: RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97:889-901
8. Dahlin K, Mager EM, Allen L, et al: Identification of genes differentially expressed in rat alveolar type I cells. Am J Respir Cell Mol Biol 2004; 31:309-316
9. Shirasawa M, Fujiwara N, Hirabayashi S, et al: Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 2004; 9:165-174
10. Schmidt AM, Yan SD, Yan SF, et al: The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000; 1498:99-111
11. Liliensiek B, Weigand MA, Bierhaus A, et al: Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004; 113:1641-1650
12. Vogl T, Propper C, Hartmann M, et al: S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem 1999; 274:25291-25296
13. Ye F, Foell D, Hirono KI, et al: Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. Am J Cardiol 2004; 94:840-844
14. Foell D, Kucharzik T, Kraft M, et al: Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003; 52:847-853
15. Parsey MV, Tuder RM, Abraham E: Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol 1998; 160:1007-1013
16. Shenkar R, Abraham E: Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: Roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 1999; 163:954-962
17. Foell D, Seeliger S, Vogl T, et al: Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 2003; 58:613-617
18. Foell D, Wittkowski H, Hammerschmidt I, et al: Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004; 50:1286-1295
19. Maris NA, de Vos AF, Dessing MC, et al: Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005; 172:878-884
20. Gu X, Chen M, Shen H, et al: Rv2131c gene product: An unconventional enzyme that is both inositol monophosphatase and fructose-1,6-bisphosphatase. Biochem Biophys Res Commun 2006; 339:897-904
21. Foell D, Hernandez-Rodriguez J, Sanchez M, et al: Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004; 204:311-316
22. Srikrishna G, Turovskaya O, Shaikh R, et al: Carboxylated glycans mediate colitis through activation of NF-kappa B. J Immunol 2005; 175:5412-5422
23. Viemann D, Strey A, Janning A, et al: Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005; 105:2955-2962
24. Viemann D, Goebeler M, Schmid S, et al: TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol 2006; 80:174-185
25. Vogl T, Ludwig S, Goebeler M, et al: MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004; 104:4260-4268
26. Abraham E, Carmody A, Shenkar R, et al: Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000; 279:L1137-L1145
27. Foell D, Kane D, Bresnihan B, et al: Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003; 42:1383-1389
28. Uchida T, Shirasawa M, Ware LB, et al: Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006; 173:1008-1015
29. Wort SJ, Evans TW: The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull 1999; 55:30-48
30. Zimmerman GA, Albertine KH, Carveth HJ, et al: Endothelial activation in ARDS. Chest 1999; 116:18S-24S
31. Ware LB, Eisner MD, Thompson BT, et al: Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004; 170:766-772
32. Carden D, Xiao F, Moak C, et al: Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol 1998; 275:H385-H392
33. Burnham EL, Taylor WR, Quyyumi AA, et al: Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005; 172:854-860
34. Schenkman KA, Zimmerman JJ: Shining some light on the development of pulmonary edema. Crit Care Med 1999; 27:2046-2047
35. Katsuoka F, Kawakami Y, Arai T, et al: Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. Biochem Biophys Res Commun 1997; 238:512-516
36. Hudson BI, Stickland MH, Futers TS, et al: Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001; 50:1505-1511
37. Hanford LE, Enghild JJ, Valnickova Z, et al: Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 2004; 279:50019-50024
38. Devaux Y, Senior RM, Ray P: RAGE: A new target for MMP-9 in the regulation of inflammatory response in the lung during oxidative stress. Am J Respir Crit Care Med 2004; 169:A456